GK Wealth Management
ANRO icon

GK Wealth Management’s Alto Neuroscience ANRO Stock Holding History

GK Wealth Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$166K Sell
6,500
-2,065
-24% -$62K 0.09% 198
2026
Q2 		$226K Buy
+8,565
New +$198K 0.12% 200

Other funds holding ANRO

Revisor Wealth Management
Revisor Wealth Management Akron, Ohio $404M AUM 18.59% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

GK Wealth Management's ANRO Position: Q3 2026 in Review

GK Wealth Management reduced its Alto Neuroscience (ANRO) stake by 24% in Q3 2026, selling an estimated $62K and leaving 6,500 shares worth $166K. The position accounts for 0.09% of the portfolio, ranked #198.

GK Wealth Management first reported a position in ANRO in Q2 2026 and has held it in 2 quarters since. The position peaked at $226K in Q2 2026. 10 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

  • GK Wealth Management held 6,500 shares of Alto Neuroscience worth $166K as of Q3 2026.
  • GK Wealth Management sold 2,065 Alto Neuroscience shares in Q3 2026, an estimated $62K.
  • Alto Neuroscience made up 0.09% of GK Wealth Management's portfolio in Q3 2026, its #198 holding.
  • GK Wealth Management first reported a position in Alto Neuroscience in Q2 2026 and has held it in 2 quarters since.
  • GK Wealth Management's Alto Neuroscience position peaked at $226K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.